Filter
3445
Filtered Results: 3445
Text search:
drug
safety
Featured
Recommendations
365
New Publications
961
Language
Document type
No document type
2009
Guidelines
550
Studies & Reports
450
Manuals
174
Strategic & Response Plan
119
Fact sheets
56
Training Material
43
Situation Updates
15
Infographics
10
Resource Platforms
8
Brochures
6
Online Courses
4
App
1
Countries / Regions
India
186
Kenya
105
Global
87
South Africa
86
Ethiopia
83
Uganda
75
Nigeria
71
Western and Central Europe
66
Sierra Leone
61
Liberia
57
Tanzania
54
Nepal
53
Myanmar / Burma
51
Zambia
50
Malawi
48
Bangladesh
45
Latin America and the Carribbean
44
Ghana
43
Africa
43
Philippines
36
Namibia
35
Rwanda
32
Zimbabwe
27
Eastern Europe
25
Russia
23
Syria
22
Cambodia
22
Ukraine
21
Lesotho
20
Asia
20
South–East Asia Region
18
Germany
17
Indonesia
17
Botswana
17
Brazil
15
Congo, Democratic Republic of
14
Middle East and North Africa
14
USA
13
Eastern Europe and Central Asia
13
South Sudan
12
East and Southern Africa
12
West and Central Africa
12
Eswatini/ Swaziland
11
Chile
10
Burkina Faso
9
Haiti
9
Mozambique
9
Senegal
8
Cameroon
8
Pakistan
8
Guinea
7
Albania
7
Tajikistan
7
Vietnam
7
Afghanistan
6
Thailand
6
Yemen
6
Venezuela
6
Colombia
5
Western Pacific Region
5
Laos
5
Iraq
4
Sudan
4
Argentina
4
Angola
4
Georgia
4
Guinea-Bissau
3
Somalia
3
Turkey
3
China
3
Peru
3
Libya
3
Paraguay
3
Bhutan
3
Moldova
3
United Kingdom
3
Spain
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Jordan
2
Lebanon
2
Central African Republic
2
North Macedonia
2
Switzerland
2
El Salvador
2
Sri Lanka
2
Palestine
2
Southern Africa
2
Canada
2
Timor Leste/ East Timor
2
Uzbekistan
2
Saudi Arabia
1
Gambia
1
Ireland
1
Singapore
1
Papua New Guinea
1
Benin
1
Austria
1
Serbia
1
Honduras
1
Bolivia
1
Madagascar
1
Mexico
1
Fiji
1
Poland
1
Armenia
1
Qatar
1
Bulgaria
1
Estonia
1
Romania
1
Lithuania
1
Iran
1
Kyrgyzstan
1
Australia
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
1305
Clinical Guidelines
350
Public Health
181
Women & Child Health
155
Key Resources
96
Capacity Building
52
Pharmacy & Technologies
48
Toolboxes
HIV
329
Mental Health
321
TB
249
AMR
223
COVID-19
215
Pharmacy
162
Caregiver
83
NTDs
81
Rapid Response
78
Ebola
72
Planetary Health
59
NCDs
59
Refugee
50
Conflict
45
Global Health Education
39
Disability
29
Specific Hazards
20
Natural Hazards
19
Cholera
17
Zika
16
Polio
13
Health Financing Toolbox
11
Social Ethics
6
Consultancy Report May 2022
Despite the continuing war in Ukraine, the Government is preparing for the country’s recovery and reconstruction. Given the magnitude of the attacks on the health infrastructure and consequent disruption to health system functioning, reconstruction of the health system is integral to the country...
For health care providers.
Sub-Saharan Africa has the highest maternal mortality in the world. According to estimates by the United Nations Maternal Mortality Estimation Inter-Agency Group (UN MMEIG)1 in September 2017, while the African Region had recorded a significant decline in maternal mortali...
Resumen para Equipos de Salud Edición 2021-2022
Las presentes recomendaciones se encuentran dirigidas a los miembros del equipo de salud que asisten niñas, niños y adolescentes (NNyA) que viven con VIH. También se dirigen a los responsables jurisdiccionales que participan en el proceso de gesti...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has...
This Tailoring Antimicrobial Resistance Programmes (TAP) process assists Member States in initiating and undertaking projects to address the spread of antimicrobial resistance (AMR) in their countries. AMR is a complex problem requiring unique, context-specific solutions. This TAP Toolbo...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding...
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional ...
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a...
Update, 23 de junio de 2022
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
This Guideline, the first for the country, draws from national health sector reforms and integration agenda as outlined in the key national strategic documents. The Guide applies lessons learnt from the SRH/HIV Linkages project and its scale-up; other national experiences and from regional and globa...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
The harmful use of alcohol causes approximately 3 million deaths every year and the overall burden of disease and injuries attributable to alcohol consumption remains unacceptably high. The pace of development and implementation of alcohol policies has been uneven in WHO regions, and resources and c...
The "Questions and Answers on Prevention and control of Alcohol related harm" has been developed by WHO country office in Viet Nam with technical contribution from national and international experts in the field. This publication provides scientific evidences on harms of alcohol use to the health of...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
Sector Environmental Guidelines, Full technical Update
